These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3615481)

  • 1. Effects of methyl acetyl phosphate on hemoglobin S: a novel acetylating agent directed towards the DPG binding site.
    Ueno H; Benjamin LJ; Manning JM
    Prog Clin Biol Res; 1987; 240():105-10. PubMed ID: 3615481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylating agent toward the 2,3-DPG binding site in hemoglobin S.
    Ueno H; Manning JM
    Am J Pediatr Hematol Oncol; 1988; 10(4):348-50. PubMed ID: 3239714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl acetyl phosphate: a novel acetylating agent. Its site-specific modification of human hemoglobin A.
    Ueno H; Pospischil MA; Kluger R; Manning JM
    J Chromatogr; 1986 May; 359():193-201. PubMed ID: 3733926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the gelation of extracellular and intracellular hemoglobin S by selective acetylation with methyl acetyl phosphate.
    Ueno H; Benjamin LJ; Pospischil MA; Manning JM
    Biochemistry; 1987 Jun; 26(11):3125-9. PubMed ID: 3607016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl acetyl phosphate as a covalent probe for anion-binding sites in human and bovine hemoglobins.
    Ueno H; Pospischil MA; Manning JM
    J Biol Chem; 1989 Jul; 264(21):12344-51. PubMed ID: 2745446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation of human hemoglobin by methyl acetylphosphate. Evidence of broad regio-selectivity revealed by NMR studies.
    Xu AS; Labotka RJ; London RE
    J Biol Chem; 1999 Sep; 274(38):26629-32. PubMed ID: 10480863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton NMR studies of the molecular basis for the anti-sickling activity of non-covalent antisickling compounds.
    Ho C; Russu IM
    Prog Clin Biol Res; 1987; 240():59-66. PubMed ID: 3615505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
    Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
    J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the polymerization of hemoglobin in high and low phosphate buffers.
    Adachi K; Asakura T
    Blood Cells; 1982; 8(2):213-24. PubMed ID: 6186320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
    Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
    J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional, oxygen-linked chloride binding sites of hemoglobin are contiguous within a channel in the central cavity.
    Ueno H; Manning JM
    J Protein Chem; 1992 Apr; 11(2):177-85. PubMed ID: 1326985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific modification of hemoglobin by methyl acetyl phosphate.
    Ueno H; Pospischil MA; Manning JM; Kluger R
    Arch Biochem Biophys; 1986 Feb; 244(2):795-800. PubMed ID: 3947090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random chemical modification of the oxygen-linked chloride-binding sites of hemoglobin: those in the central dyad axis may influence the transition between deoxy- and oxy-hemoglobin.
    Ueno H; Popowicz AM; Manning JM
    J Protein Chem; 1993 Oct; 12(5):561-70. PubMed ID: 8141998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of the anionic acetylation agent methyl acetyl phosphate with D-3-hydroxybutyrate dehydrogenase.
    Kluger R; Tsui WC
    Biochem Cell Biol; 1986 May; 64(5):434-40. PubMed ID: 3718711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anionic binding site and 2,3-DPG effect in bovine hemoglobin.
    Marta M; Patamia M; Colella A; Sacchi S; Pomponi M; Kovacs KM; Lydersen C; Giardina B
    Biochemistry; 1998 Oct; 37(40):14024-9. PubMed ID: 9760237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant sickle hemoglobin triple mutant with independent inhibitory effects on polymerization.
    Himanen JP; Mirza UA; Chait BT; Bookchin RM; Manning JM
    J Biol Chem; 1996 Oct; 271(41):25152-6. PubMed ID: 8810271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.